Sporadic reappearance of minute amounts of hepatitis C virus RNA after successful therapy stimulates cellular immune responses

Gastroenterology

Volumn 140, Issue 2, 2011, Pages 676-685.e1

  Veerapu, Naga Suresh ^a   Raghuraman, Sukanya ^a   Liang, T Jake ^a   Heller, Theo ^a   Rehermann, Barbara ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

IFN; Interferon; Liver Disease; Virology

Indexed keywords

GAMMA INTERFERON; INTERFERON; PEGINTERFERON; RIBAVIRIN; VIRUS RNA;

5' UNTRANSLATED REGION; ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; BLOOD SAMPLING; CELLULAR IMMUNITY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CONVALESCENCE; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERSISTENT INFECTION; PRIORITY JOURNAL; REINFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SEROTYPE; T LYMPHOCYTE ACTIVATION; TREATMENT DURATION; TREATMENT RESPONSE; VIRAL CLEARANCE; VIRUS TITRATION;

EID: 79251564080     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.10.048     Document Type: Article

References (34)

1. J.J. Feld, and J.H. Hoofnagle Mechanism of action of interferon and ribavirin in treatment of hepatitis C Nature 436 2005 967 972
2. T.N. Pham, S.A. MacParland, and P.M. Mulrooney Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C J Virol 78 2004 5867 5874
3. M. Radkowski, J.F. Gallegos-Orozco, and J. Jablonska Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C Hepatology 41 2005 106 114
4. T. Laskus, E.A. Operskalski, and M. Radkowski Negative-strand hepatitis C virus (HCV) RNA in peripheral blood mononuclear cells from anti-HCV-positive/ HIV-infected women J Infect Dis 195 2007 124 133
5. I. Castillo, E. Rodriguez-Inigo, and J.M. Lopez-Alcorocho Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment Clin Infect Dis 43 2006 1277 1283
6. T.N. Pham, D. King, and S.A. Macparland Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection Gastroenterology 134 2008 812 822
7. T.N. Pham, P.M. Mulrooney-Cousins, and S.E. Mercer Antagonistic expression of hepatitis C virus and α interferon in lymphoid cells during persistent occult infection J Viral Hepat 14 2007 537 548
8. I. Castillo, M. Pardo, and J. Bartolome Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown J Infect Dis 189 2004 7 14
9. J.G. McHutchison, T. Poynard, and R. Esteban-Mur Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin Hepatology 35 2002 688 693
10. T. Poynard, J. McHutchison, and M. Manns Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C Gastroenterology 122 2002 1303 1313
11. B.J. Veldt, E.J. Heathcote, and H. Wedemeyer Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis Ann Intern Med 147 2007 677 684
12. M. Buti, R. San Miguel, and M. Brosa Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis C J Hepatol 42 2005 639 645
13. W.M. Lee, J.E. Polson, and D.S. Carney Reemergence of hepatitis C virus after 8.5 years in a patient with hypogammaglobulinemia: evidence for an occult viral reservoir J Infect Dis 192 2005 1088 1092
14. A. Lin, A. Thadareddy, and M.J. Goldstein Immune suppression leading to hepatitis C virus re-emergence after sustained virological response J Med Virol 80 2008 1720 1722
15. B. Rehermann, C. Ferrari, and C. Pasquinelli The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response Nat Med 2 1996 1104 1108
16. J.H. Joncas Persistence, reactivation, and cell transformation by human herpeviruses: herpes simplex 1, 2 (HSV-1, HSV-2), cytomegalovirus (CMV), varicella-zoster (VZV), Epstein-Barr virus (EBV) Can J Microbiol 25 1979 254 260
17. M. Radkowski, A. Horban, and J.F. Gallegos-Orozco Evidence for viral persistence in patients who test positive for anti-hepatitis C virus antibodies and have normal alanine aminotransferase levels J Infect Dis 191 2005 1730 1733
18. F. Rahman, T. Heller, and Y. Sobao Effects of antiviral therapy on the cellular immune response in acute hepatitis C Hepatology 40 2004 87 97
19. T. Wakita, T. Pietschmann, and T. Kato Production of infectious hepatitis C virus in tissue culture from a cloned viral genome Nat Med 11 2005 791 796
20. M. Yi, Y. Ma, and J. Yates Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus J Virol 81 2007 629 638
21. B.D. Lindenbach, M.J. Evans, and A.J. Syder Complete replication of hepatitis C virus in cell culture Science 309 2005 623 626
22. B.D. Lindenbach Measuring HCV infectivity produced in cell culture and in vivo Methods Mol Biol 510 2009 329 336
23. C. Logvinoff, M.E. Major, and D. Oldach Neutralizing antibody response during acute and chronic hepatitis C virus infection Proc Natl Acad Sci U S A 101 2004 10149 10154
24. C. Morishima, T.R. Morgan, and J.E. Everhart Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis C Hepatology 48 2008 1412 1419
25. F. Bernardin, L. Tobler, and I. Walsh Clearance of hepatitis C virus RNA from the peripheral blood mononuclear cells of blood donors who spontaneously or therapeutically control their plasma viremia Hepatology 47 2008 1446 1452
26. S. Maylin, M. Martinot-Peignoux, and R. Moucari Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C Gastroenterology 135 2008 821 829
27. M. Hoare, W.T. Gelson, and S.M. Rushbrook Histological changes in HCV antibody-positive, HCV RNA-negative subjects suggest persistent virus infection Hepatology 48 2008 1737 1745
28. S.L. George, B.R. Bacon, and E.M. Brunt Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients Hepatology 49 2009 729 738
29. J.M. Timpe, and J.A. McKeating Hepatitis C virus entry: possible targets for therapy Gut 57 2008 1728 1737
30. S. Marukian, C.T. Jones, and L. Andrus Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells Hepatology 48 2008 1843 1850
31. A. Ploss, M.J. Evans, and V.A. Gaysinskaya Human occludin is a hepatitis C virus entry factor required for infection of mouse cells Nature 457 2009 882 886
32. V. Carreno, M. Pardo, and J.M. Lopez-Alcorocho Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels J Infect Dis 194 2006 53 60
33. Osburn WO, Fisher BE, Dowd KA, et al. Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection. Gastroenterology;138:315324.
34. L.K. Selin, M.A. Brehm, and Y.N. Naumov Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity Immunol Rev 211 2006 164 181